Regeneron Pharmaceuticals, Inc.
Competitive Ligand Binding Assays
Last updated:
Abstract:
Improved assays for the detection and optionally the quantification of anti-drug antibodies (ADAs) in a sample are provided. The disclosed assays include a protein drug capture assay format and a protein drug target capture assay format, each of which have certain advantages over existing assays.
Status:
Application
Type:
Utility
Filling date:
12 May 2020
Issue date:
19 Nov 2020